Cover Image
市場調查報告書

細胞溶解/細胞刻度的全球市場的預測 ∼2021年:各產品 (試劑、酵素、清洗液、超音波振盪器、均質機)、細胞區分、終端用戶

Cell Lysis/Cell Fractionation Market by Product (Consumables (Reagents, Enzymes, Detergent), Instruments (Sonicator, Homogenizer)), Type of Cell (Microbial, Mammalian), End User - Global Forecasts to 2021

出版商 MarketsandMarkets 商品編碼 355930
出版日期 內容資訊 英文 136 Pages
訂單完成後即時交付
價格
Back to Top
細胞溶解/細胞刻度的全球市場的預測 ∼2021年:各產品 (試劑、酵素、清洗液、超音波振盪器、均質機)、細胞區分、終端用戶 Cell Lysis/Cell Fractionation Market by Product (Consumables (Reagents, Enzymes, Detergent), Instruments (Sonicator, Homogenizer)), Type of Cell (Microbial, Mammalian), End User - Global Forecasts to 2021
出版日期: 2016年04月06日 內容資訊: 英文 136 Pages
簡介

全球細胞溶解/細胞刻度的市場預計從2016年到2021年以10.3%的年複合成長率發展,從2016年的23億5000萬美元,成長到2021年38億4000萬美元的規模。各產品中預計消耗品區分記錄最大幅成長,研究部門的投資擴大被認為是該成長的主要原因。

本報告提供全球細胞溶解/細胞刻度的市場調查,市場定義和概要,對市場成長的各種影響因素與課題,各產品及細胞的區分、終端用戶、地區的趨勢與市場規模的變化與預測,競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 市場分析:各產品
  • 市場分析:各細胞類型
  • 地區概要
  • 地區分析:各終端用戶
  • 生命週期分析:各地區

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 成長推進因素
    • 阻礙成長要素
    • 機會
    • 課題

第6章 市場分析:各產品

  • 簡介
  • 消耗品
    • 試劑、套件
      • 酵素
      • 清洗液
      • 其他
    • 拋棄式品
  • 設備
    • 超音波振盪器
    • 均質機
    • 其他

第7章 市場分析:各細胞類型

  • 簡介
  • 哺乳類細胞
  • 微生物細胞
  • 其他

第8章 市場分析:各終端用戶

  • 簡介
  • 研究實驗室、機關
  • 生物醫藥品、生物科技企業
  • 其他

第9章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞洲
  • 其他地區

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢
    • 協定、聯盟、合作
    • 收購
    • 新產品的投入
    • 擴張
    • 其他

第11章 企業簡介

  • 簡介
  • THERMO FISHER SCIENTIFIC, INC.
  • MERCK KGAA
  • BIO-RAD LABORATORIES, INC.
  • BECKMAN COULTER, INC.
  • BECTON, DICKINSON AND COMPANY
  • CELL SIGNALING TECHNOLOGY, INC.
  • MILTENYI BIOTEC
  • ROCHE DIAGNOSTICS
  • QIAGEN N.V.
  • QSONICA, LLC
    • 概要
    • 財務趨勢
    • 產品與服務
    • 策略
    • 發展趨勢等

第12章 附錄

圖表

目錄
Product Code: BT 4209

The cell lysis market is expected to reach USD 3.84 billion by 2021 from USD 2.35 billion in 2016, at a CAGR of 10.3%. The global cell lysis market is segmented based on product, type of cell, end-users, and regions. The consumables segment is expected to register the highest growth rate in the cell lysis market, by product, during the forecast period. The high growth in this segment is attributed to the increasing investments in research.

Based on end-users, the cell lysis market is segmented into research laboratories and institutes, biopharmaceutical and biotechnology companies, and others. The research laboratories and institutes segment is expected to account for the largest share of the market in 2016. Increasing prevalence of diseases and the need for development of new therapies will drive the growth of this market.

Geographically, the cell lysis market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by increasing aging population, and rising government funding in the North American countries.

The major factors contributing to the growth of the cell lysis market include increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine. Furthermore, increasing R&D spending and new product development activities by companies is another major factor driving the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.

The major players in this market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), F. Hoffman-La Roche AG (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), QIAGEN N.V. (Netherlands), Qsonica, LLC. (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the cell lysis market. The report analyses the cell lysis market by product, type of cell, end-users, and regions
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the cell lysis market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the cell lysis market
  • Market Development: Comprehensive information about emerging markets. This report analyses the market for various cell lysis market products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell lysis market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKET SEGMENTATION
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATION
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
  • 2.4. KEY DATA FROM SECONDARY SOURCES
  • 2.5. KEY DATA FROM PRIMARY SOURCES
  • 2.6. KEY INDUSTRY INSIGHTS
  • 2.7. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CELL LYSIS MARKET OVERVIEW
  • 4.2. CELL LYSIS MARKET, BY PRODUCT
  • 4.3. CELL LYSIS MARKET, BY TYPE OF CELL
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE CELL LYSIS MARKET
  • 4.5. GEOGRAPHIC ANALYSIS: CELL LYSIS MARKET, BY END USER
  • 4.6. LIFECYCLE ANALYSIS, BY REGION, 2016

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. CELL LYSIS MARKET, BY PRODUCT
    • 5.2.2. CELL LYSIS MARKET, BY TYPE OF CELL
    • 5.2.3. CELL LYSIS MARKET, BY END USER
    • 5.2.4. CELL LYSIS MARKET, BY REGION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increasing government funding for research
      • 5.3.1.2. High prevalence of diseases
      • 5.3.1.3. Expanding biotechnology and biopharmaceutical industries
      • 5.3.1.4. Growing focus on personalized medicine
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High cost of cell-based research
      • 5.3.2.2. Shortage of skilled personnel
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emerging countries to present high-growth opportunities
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Survival of small players and new entrants

6. CELL LYSIS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. CONSUMABLES
    • 6.2.1. REAGENTS AND KITS
      • 6.2.1.1. Enzymes
      • 6.2.1.2. Detergent solutions
      • 6.2.1.3. Other reagents and kits
    • 6.2.2. BEADS
    • 6.2.3. DISPOSABLES
  • 6.3. INSTRUMENTS
    • 6.3.1. SONICATORS
    • 6.3.2. HOMOGENIZERS
    • 6.3.3. OTHER INSTRUMENTS

7. CELL LYSIS MARKET, BY TYPE OF CELL

  • 7.1. INTRODUCTION
  • 7.2. MAMMALIAN CELLS
  • 7.3. MICROBIAL CELLS
  • 7.4. OTHER CELLS

8. CELL LYSIS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. RESEARCH LABORATORIES AND INSTITUTES
  • 8.3. BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 8.4. OTHERS

9. CELL LYSIS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
  • 9.4. ASIA
  • 9.5. ROW

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. AGREEMENTS, PARTNERSHIPS AND COLLABORATIONS
    • 10.3.2. ACQUISITION
    • 10.3.3. NEW PRODUCT LAUNCHES
    • 10.3.4. EXPANSION
    • 10.3.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES*

  • 11.1. INTRODUCTION
  • 11.2. THERMO FISHER SCIENTIFIC, INC.
  • 11.3. MERCK KGAA
  • 11.4. BIO-RAD LABORATORIES, INC.
  • 11.5. BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION)
  • 11.6. BECTON, DICKINSON AND COMPANY
  • 11.7. CELL SIGNALING TECHNOLOGY, INC.
  • 11.8. MILTENYI BIOTEC
  • 11.9. ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.)
  • 11.10. QIAGEN N.V.
  • 11.11. QSONICA, LLC

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. AVAILABLE CUSTOMIZATIONS
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: BIOTECHNOLOGY R&D EXPENDITURE, BY COUNTRY
  • TABLE 2: RISING INCIDENCES OF DISEASES
  • TABLE 3: EXPANDING BIOTECHNOLOGY AND BIOPHARMACEUTICAL INDUSTRIES AND HIGH PREVALENCE OF DISEASES ARE DRIVING THE CELL LYSIS MARKET
  • TABLE 4: HIGH COST OF CELL LYSIS PRODUCTS IS EXPECTED TO RESTRAIN MARKET GROWTH
  • TABLE 5: ASIAN ECONOMIES TO CREATE NEW GROWTH OPPORTUNITIES IN THE MARKET
  • TABLE 6: SURVIVAL OF SMALL PLAYERS AND NEW ENTRANTS IS A MAJOR CHALLENGE IN THE CELL LYSIS MARKET
  • TABLE 7: CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 8: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 11: CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 14: CELL LYSIS MARKET SIZE FOR ENZYMES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: CELL LYSIS MARKET SIZE FOR DETERGENT SOLUTIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: CELL LYSIS MARKET SIZE FOR OTHER REAGENTS AND KITS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: CELL LYSIS MARKET SIZE FOR BEADS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR BEADS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 19: CELL LYSIS MARKET SIZE FOR DISPOSABLES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR DISPOSABLES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 23: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 24: CELL LYSIS MARKET SIZE FOR SONICATORS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR SONICATORS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: CELL LYSIS MARKET SIZE FOR HOMOGENIZERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR HOMOGENIZERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: CELL LYSIS MARKET SIZE FOR OTHER INSTRUMENTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR OTHER INSTRUMENTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: CELL LYSIS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 31: MAMMALIAN CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: NORTH AMERICA: MAMMALIAN CELLS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: MICROBIAL CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: MICROBIAL CELLS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: OTHER CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: OTHER CELLS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 38: CELL LYSIS MARKET SIZE FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: CELL LYSIS MARKET SIZE FOR BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: CELL LYSIS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: CELL LYSIS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: NORTH AMERICA: CELL LYSIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 49: NORTH AMERICA: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: CELL LYSIS MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 51: NORTH AMERICA: CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 52: U.S.: CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 53: U.S.: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: U.S.: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: U.S.: CELL LYSIS MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: U.S.: CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 57: CANADA: CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 58: CANADA: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: CANADA: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: CANADA: CELL LYSIS MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: CANADA: CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 62: EUROPE: CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 63: EUROPE: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 64: EUROPE: CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: EUROPE: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 66: EUROPE: CELL LYSIS MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: EUROPE: CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 68: ASIA: CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 69: ASIA: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: ASIA: CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: ASIA: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: ASIA: CELL LYSIS MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: ASIA: CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 74: ROW: CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 75: ROW: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 76: ROW: CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: ROW: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 78: ROW: CELL LYSIS MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 79: ROW: CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 80: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016
  • TABLE 81: ACQUISITIONS, 2013-2016
  • TABLE 82: NEW PRODUCT LAUNCHES, 2013-2016
  • TABLE 83: EXPANSIONS, 2013-2016
  • TABLE 84: OTHER DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: TOP-DOWN APPROACH
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: CELL LYSIS MARKET SIZE, BY PRODUCT (2016 VS. 2021): CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET
  • FIGURE 7: MAMMALIAN CELLS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE CELL LYSIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 8: RESEARCH LABORATORIES AND INSTITUTES END-USER SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 9: GEOGRAPHIC SNAPSHOT OF THE CELL LYSIS MARKET, 2016
  • FIGURE 10: CELL LYSIS MARKET TO SHOWCASE HIGH GROWTH OPPORTUNITIES IN THE FORECAST PERIOD
  • FIGURE 11: CONSUMABLES SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD MARKET
  • FIGURE 12: MAMMALIAN CELLS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
  • FIGURE 13: U.S. TO COMMAND ONE-THIRD OF THE MARKET IN 2016
  • FIGURE 14: RESEARCH LABORATORIES AND INSTITUTES SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 15: ASIA TO WITNESS THE HIGHEST GROWTH RATE IN THE CELL LYSIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: CELL LYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: CONSUMABLES SEGMENT TO DOMINATE THE CELL LYSIS PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: SONICATORS SEGMENT WILL GROW AT HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 19: MAMMALIAN CELLS SEGMENT EXPECTED TO DOMINATE THE MARKET IN THE FORECAST PERIOD
  • FIGURE 20: NORTH AMERICA EXPECTED TO DOMINATE THE MICROBIAL CELLS MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: RESEARCH LABORATORIES & INSTITUTES SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN 2016
  • FIGURE 22: ASIA TO WITNESS THE HIGHEST GROWTH RATE IN THE BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET DURING THE FORECAST PERIOD
  • FIGURE 23: GEOGRAPHIC SNAPSHOT: EMERGING MARKETS TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 24: ASIA - AN ATTRACTIVE MARKET FOR CELL LYSIS
  • FIGURE 25: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 26: EUROPE: MARKET SNAPSHOT
  • FIGURE 27: EUROPE: ESTIMATED NUMBER OF NEW CANCER CASES
  • FIGURE 28: ASIA: MARKET SNAPSHOT
  • FIGURE 29: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, THE KEY GROWTH STRATEGIES FOR MARKET PLAYERS
  • FIGURE 30: GLOBAL CELL LYSIS MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 31: BATTLE FOR MARKET SHARE: AGREEMENTS, PARTNERSHIPS, AND COLLABORATION WERE THE PREFERRED STRATEGIES FOR MARKET PLAYERS
  • FIGURE 32: PRODUCT BENCHMARKING FOR TOP 5 MARKET PLAYERS
  • FIGURE 33: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 34: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 35: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 36: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 37: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 38: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • FIGURE 39: QIAGEN N.V.: COMPANY SNAPSHOT
  • FIGURE 40: MARKETSANDMARKETS KNOWLEDGE STORE SNAPSHOT
  • FIGURE 41: MARKETSANDMARKETS KNOWLEDGE STORE: HEALTHCARE INDUSTRY SNAPSHOT
Back to Top